Jørn Herrstedt (J Herrstedt)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 26

Top Topics

Clinical Practice

Histone Deacetylase

Chemotherapy Induced

Prognostic Factors

Top Venues

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Hanieh Meteran, Anja Ør Knudsen, Trine Lembrecht Jørgensen, Dorte Nielsen, Jørn Herrstedt
Carboplatin plus Paclitaxel in Combination with the Histone Deacetylate Inhibitor, Vorinostat, in Patients with Recurrent Platinum-Sensitive Ovarian Cancer. Journal of clinical medicine 13 (3) (2024)
Hanieh Meteran, Anja Ør Knudsen, Trine Lembrecht Jørgensen, Dorte Nielsen, Jørn Herrstedt
Carboplatin plus Paclitaxel in Combination with the Histone Deacetylate Inhibitor, Vorinostat, in Patients with Recurrent Platinum-Sensitive Ovarian Cancer. Journal of clinical medicine 13 (3) (2024)
Jørn Herrstedt, R Clark-Snow, C H Ruhlmann, K Jordan, F Scotté
MASCC/ESMO antiemetic guidelines: Introduction to the 2023 guidelines update. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Bernardo Leon Rapoport, Jørn Herrstedt, Rebecca Clark Snow, Venkatraman Radhakrishnan, Mitsue Saito, Rudolph M Navari, Teresa Smit
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Jørn Herrstedt, R Clark-Snow, C H Ruhlmann, K Jordan, F Scotté
MASCC/ESMO antiemetic guidelines: Introduction to the 2023 guidelines update. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Bernardo Leon Rapoport, Jørn Herrstedt, Rebecca Clark Snow, Venkatraman Radhakrishnan, Mitsue Saito, Rudolph M Navari, Teresa Smit
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Bernardo Leon Rapoport, Jørn Herrstedt, Rebecca Clark Snow, Venkatraman Radhakrishnan, Mitsue Saito, Rudolph M Navari, Teresa Smit
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Jørn Herrstedt, R Clark-Snow, C H Ruhlmann, K Jordan, F Scotté
MASCC/ESMO antiemetic guidelines: Introduction to the 2023 guidelines update. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Bernardo Leon Rapoport, Jørn Herrstedt, Rebecca Clark Snow, Venkatraman Radhakrishnan, Mitsue Saito, Rudolph M Navari, Teresa Smit
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Jørn Herrstedt, L Celio, P J Hesketh, L Zhang, R Navari, A Chan, M Saito, R Chow, M Aapro
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Bernardo Leon Rapoport, Jørn Herrstedt, Rebecca Clark Snow, Venkatraman Radhakrishnan, Mitsue Saito, Rudolph M Navari, Teresa Smit
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Jørn Herrstedt, L Celio, P J Hesketh, L Zhang, R Navari, A Chan, M Saito, R Chow, M Aapro
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Jørn Herrstedt, L Celio, P J Hesketh, L Zhang, R Navari, A Chan, M Saito, R Chow, M Aapro
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Bernardo Leon Rapoport, Jørn Herrstedt, Rebecca Clark Snow, Venkatraman Radhakrishnan, Mitsue Saito, Rudolph M Navari, Teresa Smit
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Jørn Herrstedt, L Celio, P J Hesketh, L Zhang, R Navari, A Chan, M Saito, R Chow, M Aapro
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Helena Sylow Heilmann Dominiak, Simone D Hasselsteen, Sebastian Werngreen Nielsen, Jens Rikardt Andersen, Jørn Herrstedt
Prevention of Taste Alterations in Patients with Cancer Receiving Paclitaxel- or Oxaliplatin-Based Chemotherapy-A Pilot Trial of Cannabidiol. Nutrients 15 (13) (2023)
Jørn Herrstedt, L Celio, P J Hesketh, L Zhang, R Navari, A Chan, M Saito, R Chow, M Aapro
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Jørn Herrstedt, L Celio, P J Hesketh, L Zhang, R Navari, A Chan, M Saito, R Chow, M Aapro
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Jørn Herrstedt, L Celio, P J Hesketh, L Zhang, R Navari, A Chan, M Saito, R Chow, M Aapro
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (1) (2023)
Sebastian Werngreen Nielsen, Simone Dyring Hasselsteen, Helena Sylow Heilmann Dominiak, Dejan Labudovic, Lars Reiter, Susanne Oksbjerg Dalton, Jørn Herrstedt
Oral cannabidiol for prevention of acute and transient chemotherapy-induced peripheral neuropathy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 30 (11) (2022)
Birgitte Bjørnhart, Karin Holmskov Hansen, Jon Thor Asmussen, Trine Lembrecht Jørgensen, Jørn Herrstedt, Tine Schytte
Effect and Tolerability of Immunotherapy in Patients with NSCLC with or without Brain Metastasis. Cancers 14 (7) (2022)
Sebastian Werngreen Nielsen, Sanne Lindberg, Christina Halgaard Bruvik Ruhlmann, Lise Eckhoff, Jørn Herrstedt
Addressing Chemotherapy-Induced Peripheral Neuropathy Using Multi-Frequency Vibrometry and Patient-Reported Outcomes. Journal of clinical medicine 11 (7) (2022)
Sebastian Werngreen Nielsen, Christina Halgaard Bruvik Ruhlmann, Lise Eckhoff, Dorthe Scavenius Brønnum, Jørn Herrstedt, Susanne Oksbjerg Dalton
Response to Vitetta et al. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 30 (11) (2022)
Jørn Herrstedt, Sanne Lindberg, Peter Clausager Petersen
Prevention of Chemotherapy-Induced Nausea and Vomiting in the Older Patient: Optimizing Outcomes. Drugs & aging (2021)
Sebastian Werngreen Nielsen, Lise Eckhoff, Christina Halgaard Bruvik Ruhlmann, Jørn Herrstedt, Susanne Oksbjerg Dalton
The prevalence, distribution and impact of peripheral neuropathy among Danish patients with cancer - a population-based cross-sectional study. Acta oncologica (Stockholm, Sweden) (2021)
Jørn Herrstedt, Y Summers, K Jordan, J von Pawel, A H Jakobsen, M Ewertz, S Chan, J D Naik, M Karthaus, S Dubey, R Davis, G M Fox
Amisulpride prevents nausea and vomiting associated with highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled, dose-ranging trial. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 27 (7) (2018)